Starting this year, many popular brand name medications are predicted to come off patent, opening the market for competitors to come in and create generic equivalents. Once this happens, significant price drops in these medications will appear as the companies lose their market share and more generics enter the field.
And while cheaper drugs can only be good for the consumer, what does it mean for pharmacy benefit managers (PBM), those who contract with pharmacies and work to maintain the formularies?
Changing business models
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
